We demonstrated HuR-FNP is preferentially taken up by FRA overexpressing lung cancer cells and produce tumor cell cytotoxicity by inhibiting HuR with minimal cytotoxicity to normal cells. This evidence concerns the gene ELAVL1 and lung carcinoma.